Sinopharm Group First-Half Revenue RMB 282.8 Billion, Net Profit Down 1.8%

Sinopharm Group said in a Hong Kong Stock Exchange announcement that it generated revenue of RMB 282.8 billion in the first half of 2026, down 1.1% year on year. Net profit attributable to holders of the parent company was RMB 3.404 billion in the period, a decline of 1.8% from a year earlier.

Basic earnings per share were RMB 1.09. The financial figures are compiled from the company's published results announcement.